Metsera responds to Pfizer litigation, will address claims in court

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. FIX

Go back to Metsera responds to Pfizer litigation, will address claims in court

Metsera Issues Statement in Response to Litigation

October 31, 2025 6:25 PM EDT

NEW YORK, Oct. 31, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to litigation filed against the Company by Pfizer:

"Metsera disagrees with the allegations in Pfizer's complaint and will address them in the Delaware Court of Chancery."

 

Disclosure Notice  

This release contains forward-looking information about, among other topics, Pfizer's proposed... More